Related Experiment Video
Updated: Dec 28, 2025
09:41
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
10.0K
Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic
M Cernan1, T Szotkowski1, M Hisemova2
1Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
Neoplasma
|February 18, 2020
Summary
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is rare. Allogeneic hematopoietic cell transplantation improved remission rates and survival in Czech patients with relapsed or refractory BPDCN.
Area of Science:
- Hematology
- Oncology
Background:
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy.
- BPDCN is characterized by aggressive behavior and poor prognosis.
Purpose of the Study:
- To analyze the incidence and therapeutic outcomes of BPDCN in the Czech Republic from 2000 to 2017.
- To contribute to a global understanding of BPDCN by presenting specific regional data.
Main Methods:
- Retrospective analysis of 14 diagnosed and treated BPDCN patients.
- Evaluation of treatment regimens including induction therapy and allogeneic hematopoietic cell transplantation.
- Analysis of patient demographics, disease characteristics, treatment responses, and survival outcomes.
Main Results:
- Median age at diagnosis was 39 years; 71% had initial skin involvement, 64% bone marrow infiltration.
- Complete remission was achieved in 43% after lymphoblastic leukemia/lymphoma induction and 21% after myeloid leukemia regimens.
- Allogeneic hematopoietic cell transplantation was associated with longer overall survival (16.4 vs. 8.1 months) and improved remission rates in refractory/relapsed disease.
Conclusions:
- Allogeneic hematopoietic cell transplantation is effective for achieving complete remission in refractory/relapsed BPDCN.
- Relapse of the disease is a significant predictor of mortality.
- This study provides crucial data on BPDCN incidence and outcomes in the Czech Republic.
